Format

Send to

Choose Destination
J Manag Care Spec Pharm. 2019 Jul;25(7):738-741. doi: 10.18553/jmcp.2019.25.7.738.

Value-Based Insurance Design: Current Evidence and Future Directions.

Author information

1
1 Kaiser Permanente Washington Health Research Institute, Seattle, and The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle.

Abstract

Value-based insurance design (VBID) is an approach to designing insurance to align the use of health care services with some notion of value. While there is substantial federal interest in VBID and a growing body of evidence of its effects among populations covered by employer-sponsored plans, much of the focus has been on VBIDs that solely reduce cost sharing for certain treatments. The minority of VBIDs that have identified and increased cost sharing for low-value treatments have produced some promising results. Looking to the future, health plans should continue to develop and benefit from innovations in formulary design and health information technology that distinguishes and incentivizes high-value drugs in a patient-specific manner. DISCLOSURES: No funding contributed to the writing of this article. The author has nothing to disclose.

PMID:
31232202
DOI:
10.18553/jmcp.2019.25.7.738
Free full text

Supplemental Content

Full text links

Icon for Academy of Managed Care Pharmacy
Loading ...
Support Center